Pulmonary arterial hypertension (PAH) is a rapidly progressive disease that is fatal when left untreated. It is characterized by pulmonary vasoconstriction and vascular remodeling, which in turn leads to increased pulmonary vascular resistance and arterial pressure, decreased cardiac output, and ultimately right heart failure. In recent years, standard of care treatment has moved away from sequential monotherapy to upfront combination therapy. To ensure that clinicians are well-equipped to provide optimal PAH management, this educational program will provide up-to-date information on clinical trial evidence regarding the efficacy and safety of combination (dual and triple) treatment strategies. Additionally, the program will also address the role of noninvasive testing (eg, echocardiography) in early diagnosis, assessment of treatment response, and disease monitoring, as well as the importance of multidisciplinary care throughout the course of care.
Vallerie V. McLaughlin, MD
Department of Internal Medicine
University of Michigan
Ann Arbor, Michigan
John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA
Director, Pulmonary Hypertension Comprehensive Care Center
Medical Director, Cardiovascular Medical Unit
University of Utah Hospital
Faculty Director of Cardiology Education
University of Utah School of Medicine
Salt Lake City, Utah
This educational initiative has been designed for pulmonologists, cardiologists, and nurse practitioners, physician assistants, nurses, and other healthcare providers involved in the care of patients with PAH.
Upon completion of this educational activity, participants will be able to:
There is no registration fee for participating in this activity. To register, click the registration buttons on this page or call Integrity Continuing Education, Inc. at 1-855-835-4004.
Physician Continuing Education
Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Integrity Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or firstname.lastname@example.org.
Integrity Continuing Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following faculty/planners reported the financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
Vallerie McLaughlin, MD
Consultant: Acceleron, Aerovate, Altavant, Bayer, Caremark, Civi Biopharma, Corvista, Gossamer Bio, Jassen, Merck, United Therapeutics
University Grant Support: Acceleron, Jassen, Sonovie, United Therapeutics
John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA
Speakers Bureau: Bayer, Janssen PH, United Therapeutics
The Integrity Continuing Education planners and managers have nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
When you participate in an online educational activity sponsored by Integrity Continuing Education, you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)
Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10
For optimal performance, the use of Internet Explorer below 8 is not recommended
For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Provided by Integrity Continuing Education.
The activity has been supported by an educational grant by Actelion Pharmaceuticals US Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.
5:00 PM – 5:50 PM Interactive Presentation
5:50 PM -6:00 PM Question & Answer Session/Closing Remarks
Dinner is On Us: Earn a $30 Uber Eats Credit
The symposium has gone virtual, but you can still dine with us. All participants who complete the following steps will be provided with a $30 Uber eats card compliments of Integrity Continuing Education:
Upon completion of all steps, a link will be provided to claim your $30 Uber Eats credit.